ROKIT Healthcare Inc. (KOSDAQ:376900)

Sage Therapeutics Statistics

Total Valuation

KOSDAQ:376900 has a market cap or net worth of KRW 244.48 billion. The enterprise value is 291.21 billion.

Market Cap	244.48B
Enterprise Value	291.21B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:376900 has 15.41 million shares outstanding. The number of shares has decreased by -33.86% in one year.

Current Share Class	15.41M
Shares Outstanding	15.41M
Shares Change (YoY)	-33.86%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	24.96%
Owned by Institutions (%)	n/a
Float	11.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.09
PB Ratio	-5.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-39.38
EV / Sales	21.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-38.97

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.44
Interest Coverage	-0.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-29.15%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	14.03%
Revenue Per Employee	187.70M
Profits Per Employee	-102.70M
Employee Count	72
Asset Turnover	1.11
Inventory Turnover	5.00

Taxes

In the past 12 months, KOSDAQ:376900 has paid 352.74 million in taxes.

Income Tax	352.74M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	16,234.60
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.67
Average Volume (20 Days)	487,960

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:376900 had revenue of KRW 13.51 billion and -7.39 billion in losses. Loss per share was -932.04.

Revenue	13.51B
Gross Profit	6.12B
Operating Income	-5.68B
Pretax Income	-7.09B
Net Income	-7.39B
EBITDA	-4.75B
EBIT	-5.68B
Loss Per Share	-932.04

Balance Sheet

The company has 5.92 billion in cash and 18.22 billion in debt, giving a net cash position of -12.30 billion or -797.63 per share.

Cash & Cash Equivalents	5.92B
Total Debt	18.22B
Net Cash	-12.30B
Net Cash Per Share	-797.63
Equity (Book Value)	-43.00B
Book Value Per Share	-9,658.34
Working Capital	-41.82B

Cash Flow

In the last 12 months, operating cash flow was -7.40 billion and capital expenditures -72.96 million, giving a free cash flow of -7.47 billion.

Operating Cash Flow	-7.40B
Capital Expenditures	-72.96M
Free Cash Flow	-7.47B
FCF Per Share	-484.77

Margins

Gross margin is 45.30%, with operating and profit margins of -42.01% and -54.71%.

Gross Margin	45.30%
Operating Margin	-42.01%
Pretax Margin	-52.43%
Profit Margin	-54.71%
EBITDA Margin	-35.14%
EBIT Margin	-42.01%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:376900 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	33.86%
Shareholder Yield	n/a
Earnings Yield	-3.02%
FCF Yield	-3.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:376900 has an Altman Z-Score of -14.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.79
Piotroski F-Score	2